Literature DB >> 34061288

SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors.

Zheng Yao Low1, Ashley Jia Wen Yip1, Anshika Sharma1, Sunil K Lal2,3.   

Abstract

The Coronavirus Disease 2019 (COVID-19), a pneumonic disease caused by the SARS Coronavirus 2 (SARS-CoV-2), is the 7th Coronavirus to have successfully infected and caused an outbreak in humans. Genome comparisons have shown that previous isolates, the SARS-related coronavirus (SARSr-CoV), including the SARS-CoV are closely related, yet different in disease manifestation. Several explanations were suggested for the undetermined origin of SARS-CoV-2, in particular, bats, avian and Malayan pangolins as reservoir hosts, owing to the high genetic similarity. The general morphology and structure of all these viral isolates overlap with analogous disease symptoms such as fever, dry cough, fatigue, dyspnoea and headache, very similar to the current SARS-CoV-2. Chest CT scans for SARS-CoV-2, SARS-CoV and MERS-CoV reveal pulmonary lesions, bilateral ground-glass opacities, and segmental consolidation in the lungs, a common pathological trait. With greatly overlapping similarities among the previous coronavirus, the SARS-CoV, it becomes interesting to observe marked differences in disease severity of the SARS-CoV-2 thereby imparting it the ability to rapidly transmit, exhibit greater stability, bypass innate host defences, and increasingly adapt to their new host thereby resulting in the current pandemic. The most recent B.1.1.7, B.1.351 and P.1 variants of SARS-CoV-2, highlight the fact that changes in amino acids in the Spike protein can contribute to enhanced infection and transmission efficiency. This review covers a comparative analysis of previous coronavirus outbreaks and highlights the differences and similarities among different coronaviruses, including the most recent isolates that have evolved to become easily transmissible with higher replication efficiency in humans.

Entities:  

Keywords:  COVID-19; Coronavirus; Outbreak; Pandemic; SARS-CoV-2; Virus

Year:  2021        PMID: 34061288     DOI: 10.1007/s11262-021-01846-9

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  60 in total

1.  Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus.

Authors:  Volker Thiel; Jens Herold; Barbara Schelle; Stuart G Siddell
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

Review 2.  The severe acute respiratory syndrome.

Authors:  Joseph S M Peiris; Kwok Y Yuen; Albert D M E Osterhaus; Klaus Stöhr
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 3.  Toxic effects of anticonvulsants: general principles.

Authors:  H Hooshmand
Journal:  Pediatrics       Date:  1974-04       Impact factor: 7.124

4.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

5.  Essential tremor and buccolinguofacial dyskinesias.

Authors:  P Martinelli; A S Gabellini
Journal:  Acta Neurol Scand       Date:  1982-12       Impact factor: 3.209

Review 6.  Middle East respiratory syndrome.

Authors:  Alimuddin Zumla; David S Hui; Stanley Perlman
Journal:  Lancet       Date:  2015-06-03       Impact factor: 79.321

Review 7.  Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses.

Authors:  Shuo Su; Gary Wong; Weifeng Shi; Jun Liu; Alexander C K Lai; Jiyong Zhou; Wenjun Liu; Yuhai Bi; George F Gao
Journal:  Trends Microbiol       Date:  2016-03-21       Impact factor: 17.079

8.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

9.  Coronavirus immunogens.

Authors:  L J Saif
Journal:  Vet Microbiol       Date:  1993-11       Impact factor: 3.293

10.  The proximal origin of SARS-CoV-2.

Authors:  Kristian G Andersen; Andrew Rambaut; W Ian Lipkin; Edward C Holmes; Robert F Garry
Journal:  Nat Med       Date:  2020-04       Impact factor: 87.241

View more
  6 in total

Review 1.  Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.

Authors:  Ashley Jia Wen Yip; Zheng Yao Low; Vincent T K Chow; Sunil K Lal
Journal:  Viruses       Date:  2022-06-20       Impact factor: 5.818

Review 2.  The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression.

Authors:  Zheng Yao Low; Ashley Jia Wen Yip; Vincent T K Chow; Sunil K Lal
Journal:  Rev Med Virol       Date:  2021-09-21       Impact factor: 11.043

3.  Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Biomolecules       Date:  2022-04-25

Review 4.  Repositioning anticancer drugs as novel COVID-19 antivirals: targeting structural and functional similarities between viral proteins and cancer.

Authors:  Zheng Yao Low; Ashley Jia Wen Yip; Sunil Kumar Lal
Journal:  Expert Rev Mol Med       Date:  2022-04-22       Impact factor: 7.615

5.  Epidemiologic characteristics of SARS-CoV-2 in Wuhan, other regions of China, and globally based on data gathered from January 2020 to February 2021.

Authors:  Song Fengjiao; Li Xiaodong; Li Jian; Liu Hui
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

Review 6.  SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.

Authors:  Zheng Yao Low; Nur Zawanah Zabidi; Ashley Jia Wen Yip; Ashwini Puniyamurti; Vincent T K Chow; Sunil K Lal
Journal:  Viruses       Date:  2022-09-08       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.